EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

ASIC Moves to Cut Sell-Side Research Guide From 42 Pages to Eight

Posted: 23rd Jul 2026

Australia's corporate regulator proposed today (Thursday) to replace its 42-page guidance on sell-side research with an eight-page, principles-based document. The Australian Securities and Investments Commission said the rewrite should draw more analyst coverage into initial public offerings and other capital raisings.

Sell-side research is the analysis investment banks and stockbrokers hand to clients before they buy, including the notes circulated ahead of a float.

ASIC wants the guide covering it stripped of prescription, part of a cleanup that has already removed more than 9,000 pages of regulatory content.

Analysts Get Closer to Deals as Pay Rules Hold

The draft keeps the harder edges. Analyst pay cannot be tied to corporate advisory revenue, research teams stay physically and technologically separated from advisory and sales desks, and senior management sets research budgets with no advisory input.

Analysts also cannot pitch for capital raising mandates unless they have been wall-crossed, and once they are, they cannot publish on the issuer until the deal completes. ASIC said its expectations on conflicts, inside information and research independence are unchanged.

On analyst involvement in live deals, the draft is direct about the cost. Firms need strong controls and should "avoid them where possible," the document says of the conflicts created when analysts deal with advisory teams or issuers.

Australia's Listings Slide Sets the Backdrop

ASIC has spent 18 months on the shrinking public market. It published a discussion paper on public and private markets in February 2025, began a two-year fast-track IPO trial that June, and set out a capital markets roadmap in November.

The regulator has also opened the listings business itself. Cboe won approval in late 2025 to host IPOs and dual listings, ending the ASX's effective monopoly on new floats.

Retail brokerages sit in the pipeline ASIC is trying to fill. BlackBull Markets, the Auckland-based CFD firm, ran a non-deal roadshow with Barrenjoey, UBS and Forsyth Barr ahead of a possible listing in Sydney and Wellington.

London Rewrote Its Research Rules First

The UK came at the same problem from the payment side. The Financial Conduct Authority proposed letting asset managers bundle research and execution payments again in April 2024, unwinding part of the MiFID II regime that forced research to be priced separately from trade execution.

London rebuilt its listing rulebook in the same stretch. The FCA replaced the premium and standard segments with a single listing category in July 2024.

Simplification programs are running in parallel elsewhere. ASIC's progress report in May said email lodgement had expanded to 88 forms and that roughly 45,000 paper filings a year had been eliminated, while ESMA has said MiFID II disclosure rules were pushing retail investors out of capital markets.

Two Consultations, One Month to Respond

One piece is left open. ASIC asked for views on how valuation information appears in investor education reports, the analyst notes released before a prospectus is lodged, and on whether corporate advisory teams should be allowed to fact check drafts.

The draft bars advisory teams from that step, leaving it to compliance, legal advisers and the issuer with all valuations redacted. Anyone arguing for something looser has been told to explain how it would support IPO activity and what controls would come with it.

A second consultation landed the same day. ASIC proposed remaking the instrument that exempts low-volume financial markets from holding an Australian market licence, lifting the transaction value threshold to A$2.5 million (about $1.75 million) from A$1.5 million, a level untouched since 2016.

That instrument sunsets on October 1, the same date as two AFS licensing relief instruments the regulator moved to preserve in May. Feedback on the low-volume paper closes on August 20, a day before submissions on the research guide.

This article was written by Damian Chmiel at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross